Renovo News
-
17th April 2008Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the reduction of scarring, today announces positive results of the planned 12 month follow-up analysis of two Juvi...Weiterlesen
-
3rd April 2008Renovo is pleased to announce that Dr Sharon O'Kane, CSO, was named as the Entrepeneur of the Year at the inaugural Northwest Women in Business Awards in Merseyside last week....Weiterlesen
-
17th März 2008Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the reduction of scarring and acceleration of healing, announces that Professor Mark Ferguson, Chief Executive Off...Weiterlesen
-
3rd März 2008An analyst briefing will be held at 14:00 UK time today at Buchanan Communications, 45 Moorfields London, EC2Y 9AE....Weiterlesen
-
15th Februar 2008Ahead of its Annual General Meeting to be held at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE on 20 February 2008, Renovo Group plc (LSE: RNVO) today publishes its firs...Weiterlesen
-
10th Oktober 2007RENOVO WINS EUROPEAN BIOTECHNICA AWARD...Weiterlesen
-
12th September 2007RENOVO GROUP PLC(“Renovo” or “the Company”)...Weiterlesen